Cesca Therapeutics Announces Change In Executive Leadership

Cesca Therapeutics Inc. KOOL, an autologous cell-based regenerative medicine company, today announced it intends to embark on a nationwide search for a new Chief Executive Officer. Robin C. Stracey, currently a member of the Company's Board of Directors, will serve as Interim CEO pending the new hire. Craig W. Moore, Chairman of Cesca Therapeutics' Board of Directors stated, "In line with the Company's business plan, greater emphasis is now being placed on achieving major clinical, regulatory and reimbursement milestones. The Board has therefore decided to commence the search for a CEO with extensive experience in developing and commercializing products in what is a clinically demanding and highly regulated therapeutic arena." He added, "Robin Stracey will serve as the Company's CEO in the interim, and Matthew Plavan, the Company's former CEO, will be retained as an advisor during the process. Matthew played a pivotal role in the creation of Cesca Therapeutics through the merger between ThermoGenesis Corp. and TotipotentRX Corporation, and we thank him for his many exceptional contributions." Robin C. Stracey, (56) was appointed to the Board of Directors in July 2011. Mr. Stracey has been the President and Chief Executive Officer at both publicly-traded and privately held companies in the life sciences sector, including Integrated Fluidics, Inc., Cantimer Incorporated, and Applied Imaging Corporation. Mr. Stracey has also held senior executive positions at Thermo Electron Corporation, now Thermo Fisher Scientific, and Dade Behring Inc., now Siemens Healthcare. Mr. Stracey has a B.S. degree with honors from the University of Nottingham in the United Kingdom. He will maintain offices in each of Cesca's Rancho Cordova and Emeryville facilities. Robin Stracey, Interim CEO of Cesca stated, "I look forward to working with the Board of Directors and the executive team to ensure that we continue to effectively execute Cesca's strategy while we identify and recruit the best possible permanent CEO for the Company."